DRDO’s Covid antibody testing kit
May 21, 2021
The kit has a high sensitivity of 97%, specificity of 99%
Conducting sero surveillance studies for Covid-19 will now be cheaper and easier with Indian defence scientists developing an indigenous antibody detection kit with high sensitivity and specificity.
Validation The kit, developed by researchers at the Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation, has already undergone extensive validation using more than 1,000 patient samples at various Covid-designated hospitals in Delhi. It has already been validated by the Indian Council of Medical Research and has received regulatory approval of the Drugs Controller General of India, said a statement on Friday.
DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19
DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19
ANI / Updated: May 21, 2021, 17:05 IST
DRDO) has developed an
COVID.
DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd.
According to DRDO, the kit can detect spike as well as nucleocapsid (S and N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.
The DIPCOVAN kit can detect both spikes as well as nucleocapsid (S&N) proteins of the SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent
The Defence Research and Development Organisation (DRDO) has developed an antibody detection kit known as Dipcovan, which is expected to be available at Rs 75 per test in the market from June first week onwards.The kit has been developed by the .
After 2-DG drug, DRDO develops Covid antibody detection kit
DRDO said three batches of the product were validated for the last one year. The antibody detection kit was approved by the Indian Council of Medical Research (ICMR) in April 2021.
Share Via Email
| A+A A-
The kit is believed to be very useful for understanding COVID-19 epidemiology and assessing an individual s previous SARS-CoV-2 exposure. (Photo | @DRDO India) By Express News Service
NEW DELHI: The Defence Research and Development Organisation (DRDO) has developed an antibody test kit for the early screening of COVID.
DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd.